372 related articles for article (PubMed ID: 37491740)
21. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
Li B; Cui Y; Diehn M; Li R
JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
[TBL] [Abstract][Full Text] [Related]
22. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma.
Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q
Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484
[TBL] [Abstract][Full Text] [Related]
23. Beyond binary: bridging neutrophil diversity to new therapeutic approaches in NSCLC.
Horvath L; Puschmann C; Scheiber A; Martowicz A; Sturm G; Trajanoski Z; Wolf D; Pircher A; Salcher S
Trends Cancer; 2024 May; 10(5):457-474. PubMed ID: 38360439
[TBL] [Abstract][Full Text] [Related]
24. The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy.
Kim SR; Chun SH; Kim JR; Kim SY; Seo JY; Jung CK; Gil BM; Kim JO; Ko YH; Woo IS; Shim BY; Hong SH; Kang JH
BMC Cancer; 2021 Jan; 21(1):19. PubMed ID: 33402127
[TBL] [Abstract][Full Text] [Related]
25. Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer.
Backman M; Strell C; Lindberg A; Mattsson JSM; Elfving H; Brunnström H; O'Reilly A; Bosic M; Gulyas M; Isaksson J; Botling J; Kärre K; Jirström K; Lamberg K; Pontén F; Leandersson K; Mezheyeuski A; Micke P
Eur J Cancer; 2023 May; 185():40-52. PubMed ID: 36963351
[TBL] [Abstract][Full Text] [Related]
26. IFNAR1 Deficiency Impairs Immunostimulatory Properties of Neutrophils in Tumor-Draining Lymph Nodes.
Hussain T; Domnich M; Bordbari S; Pylaeva E; Siakaeva E; Spyra I; Ozel I; Droege F; Squire A; Lienenklaus S; Sutter K; Hasenberg A; Gunzer M; Lang S; Jablonska J
Front Immunol; 2022; 13():878959. PubMed ID: 35833131
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive Integrative Analysis Reveals the Association of
Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
[TBL] [Abstract][Full Text] [Related]
28. Construction of a TAN-associated risk score model with integrated multi-omics data analysis and clinical validation in gastric cancer.
Xu Z; Zhang L; Wang X; Pan B; Zhu M; Wang T; Xu W; Li L; Wei Y; Wu J; Zhou X
Life Sci; 2024 Jul; 349():122731. PubMed ID: 38782354
[TBL] [Abstract][Full Text] [Related]
29. Tumour-associated neutrophils in patients with cancer.
Shaul ME; Fridlender ZG
Nat Rev Clin Oncol; 2019 Oct; 16(10):601-620. PubMed ID: 31160735
[TBL] [Abstract][Full Text] [Related]
30. Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy.
Li C; Pan J; Luo J; Chen X
BMC Pulm Med; 2021 Nov; 21(1):389. PubMed ID: 34844602
[TBL] [Abstract][Full Text] [Related]
31. A signature of tumor immune microenvironment genes associated with the prognosis of non‑small cell lung cancer.
Li J; Li X; Zhang C; Zhang C; Wang H
Oncol Rep; 2020 Mar; 43(3):795-806. PubMed ID: 32020214
[TBL] [Abstract][Full Text] [Related]
32. Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma.
Chung JY; Tang PC; Chan MK; Xue VW; Huang XR; Ng CS; Zhang D; Leung KT; Wong CK; Lee TL; Lam EW; Nikolic-Paterson DJ; To KF; Lan HY; Tang PM
Nat Commun; 2023 Mar; 14(1):1794. PubMed ID: 37002229
[TBL] [Abstract][Full Text] [Related]
33. Yi Qi Chu Tan Formula (YQCTF) inhibited the progress of lung cancer via regulating tumor-associated neutrophil: An integrated study of network pharmacology, proteomics and pharmacodynamics.
Le-Xin C; Ming-Jun L; Chun-Qi X; Jia-Xin Z; Jing-Ya Y; Li-Xin N; Mei-Qi W; En-Xin Z; Xiao-Jun Z
J Ethnopharmacol; 2024 Jan; 318(Pt B):116943. PubMed ID: 37532072
[TBL] [Abstract][Full Text] [Related]
34. Immune Cell Composition in Human Non-small Cell Lung Cancer.
Stankovic B; Bjørhovde HAK; Skarshaug R; Aamodt H; Frafjord A; Müller E; Hammarström C; Beraki K; Bækkevold ES; Woldbæk PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
Front Immunol; 2018; 9():3101. PubMed ID: 30774636
[TBL] [Abstract][Full Text] [Related]
35. [Clinical significance of CD4+ CD25+ regulatory T-cells detection in tumor-draining lymph nodes of nonsmall cell lung cancer patients].
Su YJ; Ren K; Li H; Ren XB; Wang CL
Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):922-6. PubMed ID: 18478932
[TBL] [Abstract][Full Text] [Related]
36. A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma.
Wu J; Li L; Zhang H; Zhao Y; Zhang H; Wu S; Xu B
Oncogene; 2021 Jul; 40(26):4413-4424. PubMed ID: 34108619
[TBL] [Abstract][Full Text] [Related]
37. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
Zhou SL; Zhou ZJ; Hu ZQ; Huang XW; Wang Z; Chen EB; Fan J; Cao Y; Dai Z; Zhou J
Gastroenterology; 2016 Jun; 150(7):1646-1658.e17. PubMed ID: 26924089
[TBL] [Abstract][Full Text] [Related]
38. Integrating Single-cell RNA-seq to construct a Neutrophil prognostic model for predicting immune responses in non-small cell lung cancer.
Pang J; Yu Q; Chen Y; Yuan H; Sheng M; Tang W
J Transl Med; 2022 Nov; 20(1):531. PubMed ID: 36401283
[TBL] [Abstract][Full Text] [Related]
39. High PD-L1 Expression Correlates with an Immunosuppressive Tumour Immune Microenvironment and Worse Prognosis in
Tian X; Li Y; Huang Q; Zeng H; Wei Q; Tian P
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371571
[TBL] [Abstract][Full Text] [Related]
40. Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic.
Vilariño N; Bruna J; Bosch-Barrera J; Valiente M; Nadal E
Cancer Treat Rev; 2020 Sep; 89():102067. PubMed ID: 32682248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
